Hemostasis, platelet functions, serotonin and serum lipids during omega-3 fatty acid treatment in patients with glomerulonephritis.
Malyszko
J S
JS
Malyszko
J
J
Pawlak
D
D
Buczko
W
W
Myśliwiec
M
M
D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002784:Cholesterol / Q000097:blood; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000627:therapeutic use*; D005340:Fibrinogen / Q000032:analysis; D005395:Fish Oils / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D005527:Food, Fortified; D005921:Glomerulonephritis / Q000097:blood* / Q000178:diet therapy*; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D010974:Platelet Aggregation / Q000187:drug effects; D011507:Proteinuria; D012701:Serotonin / Q000097:blood*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D015525:Fatty Acids, Omega-3; D005395:Fish Oils; D008055:Lipids; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D014280:Triglycerides; D012701:Serotonin; D005340:Fibrinogen; D002784:Cholesterol